OmniAb (OABI) Total Current Liabilities (2021 - 2026)
OmniAb (OABI) reported Total Current Liabilities of $13.6 million for Q1 2026, up 18.93% year-over-year from $11.4 million in Q1 2025, and down 16.54% quarter-over-quarter from $16.3 million in Q4 2025.
OmniAb (OABI) Total Current Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Total Current Liabilities data on file, last reported at $13.6 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $13.6 million, up 18.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.6 million (up 18.93% YoY), and the FY2025 annual result was $16.3 million, up 7.73% from the prior year.
- Total Current Liabilities declined to $13.6 million in Q1 2026 per OABI's latest filing, from $16.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $26.0 million in Q4 2022 and troughed at $5.5 million in Q1 2022.
- A 5-year average of $15.9 million and a median of $14.4 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities jumped 10598.67% in 2022, then tumbled 42.53% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $26.0 million in 2022, then declined by 11.17% to $23.1 million in 2023, then sank by 34.73% to $15.1 million in 2024, then rose by 7.73% to $16.3 million in 2025, then dropped by 16.54% to $13.6 million in 2026.
- Business Quant data shows OABI's Total Current Liabilities at $13.6 million in Q1 2026, $16.3 million in Q4 2025, and $13.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 13.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.57 Mn |
| Dec 31, 2025 | 16.25 Mn |
| Sep 30, 2025 | 13.28 Mn |
| Jun 30, 2025 | 12.64 Mn |
| Mar 31, 2025 | 11.41 Mn |
| Dec 31, 2024 | 15.09 Mn |
| Sep 30, 2024 | 14.40 Mn |
| Jun 30, 2024 | 14.15 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 23.12 Mn |
| Sep 30, 2023 | 25.06 Mn |
| Jun 30, 2023 | 24.24 Mn |
| Mar 31, 2023 | 21.68 Mn |
| Dec 31, 2022 | 26.02 Mn |
| Sep 30, 2022 | 10.27 Mn |
| Jun 30, 2022 | 6.98 Mn |
| Mar 31, 2022 | 5.46 Mn |
| Dec 31, 2021 | 20.58 Mn |
| Sep 30, 2021 | 95,969.00 |